# Transplantation: Methods and Outcomes

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/transplantation-methods-and-outcomes/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers covers advancements in organ transplantation, including lung and heart transplants, rejection mechanisms such as allograft vasculopathy and bronchiolitis obliterans syndrome, the use of ex vivo perfusion, primary graft dysfunction, and donor selection criteria. It also discusses immunosuppressive therapy and its impact on post-transplant outcomes. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11189 |
| Works | 395 |

## Topic papers all

Showing 15 of 395.

- [Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant](https://scholariq.org/papers/comparison-of-mortality-in-all-patients-on-dialysis-patients-on-dialysis/)
- [Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure](https://scholariq.org/papers/long-term-use-of-a-left-ventricular-assist-device-for-end-stage-heart-failure/)
- [Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension-the-task/)
- [Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device](https://scholariq.org/papers/advanced-heart-failure-treated-with-continuous-flow-left-ventricular-assist/)
- [A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension](https://scholariq.org/papers/a-comparison-of-continuous-intravenous-epoprostenol-prostacyclin-with/)
- [Chronic Renal Failure after Transplantation of a Nonrenal Organ](https://scholariq.org/papers/chronic-renal-failure-after-transplantation-of-a-nonrenal-organ/)
- [Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis](https://scholariq.org/papers/clinical-practice-guideline-the-diagnosis-management-and-prevention-of/)
- [Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation](https://scholariq.org/papers/use-of-a-continuous-flow-device-in-patients-awaiting-heart-transplantation/)
- [The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients](https://scholariq.org/papers/the-international-society-of-heart-and-lung-transplantation-guidelines-for-the/)
- [The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update](https://scholariq.org/papers/the-2016-international-society-for-heart-lung-transplantation-listing-criteria/)
- [The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary](https://scholariq.org/papers/the-2013-international-society-for-heart-and-lung-transplantation-guidelines-for/)
- [Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions](https://scholariq.org/papers/banff-2013-meeting-report-inclusion-of-c4d-negative-antibody-mediated-rejection/)
- [Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction](https://scholariq.org/papers/effect-of-cyclosporine-on-reperfusion-injury-in-acute-myocardial-infarction/)
- [A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report](https://scholariq.org/papers/a-fully-magnetically-levitated-left-ventricular-assist-device-final-report/)
- [REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY](https://scholariq.org/papers/reversibility-of-lymphomas-and-lymphoproliferative-lesions-developing-under/)

## Topic primary papers

Showing 15 of 158.

- [The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients](https://scholariq.org/papers/the-international-society-of-heart-and-lung-transplantation-guidelines-for-the/)
- [The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update](https://scholariq.org/papers/the-2016-international-society-for-heart-lung-transplantation-listing-criteria/)
- [The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match](https://scholariq.org/papers/the-international-thoracic-organ-transplant-registry-of-the-international-2/)
- [The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time](https://scholariq.org/papers/the-registry-of-the-international-society-for-heart-and-lung-transplantation/)
- [Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006](https://scholariq.org/papers/listing-criteria-for-heart-transplantation-international-society-for-heart-and/)
- [The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match](https://scholariq.org/papers/the-international-thoracic-organ-transplant-registry-of-the-international-7/)
- [International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010](https://scholariq.org/papers/international-society-for-heart-and-lung-transplantation-working-formulation-of/)
- [The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report—2017; Focus Theme: Allograft ischemic time](https://scholariq.org/papers/the-registry-of-the-international-society-for-heart-and-lung-transplantation-2/)
- [Report from a consensus conference on primary graft dysfunction after cardiac transplantation](https://scholariq.org/papers/report-from-a-consensus-conference-on-primary-graft-dysfunction-after-cardiac/)
- [The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first pediatric heart transplantation report—2018; Focus theme: Multiorgan Transplantation](https://scholariq.org/papers/the-international-thoracic-organ-transplant-registry-of-the-international/)
- [The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients](https://scholariq.org/papers/the-international-society-for-heart-and-lung-transplantation-ishlt-guidelines/)
- [The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient characteristics](https://scholariq.org/papers/the-international-thoracic-organ-transplant-registry-of-the-international-3/)
- [Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection](https://scholariq.org/papers/circulating-cell-free-dna-enables-noninvasive-diagnosis-of-heart-transplant/)
- [The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report—2018; Focus Theme: Multiorgan Transplantation](https://scholariq.org/papers/the-international-thoracic-organ-transplant-registry-of-the-international-6/)
- [Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial](https://scholariq.org/papers/ex-vivo-perfusion-of-donor-hearts-for-human-heart-transplantation-proceed-ii-a/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.